These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35468616)

  • 1. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
    Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
    Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of single nucleotide polymorphisms associated with steroid-induced ocular hypertension.
    Badrinarayanan L; Chitipothu S; Ramasubramanyan S; Sripriya S; Rishi P; Rishi E; George R; Lakshmi BS; Elchuri SV
    Int J Ophthalmol; 2020; 13(8):1294-1305. PubMed ID: 32821685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
    Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
    Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
    Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
    Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of clinical outcomes of raised intraocular pressure following intravitreal triamcinolone acetonide injection.
    Singh P; Krishnaprasad R; Ayachit G; Joshi S
    Rom J Ophthalmol; 2024; 68(1):37-44. PubMed ID: 38617725
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
    Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
    Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
    Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
    J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation.
    Choi W; Bae HW; Shin HJ; Kim EW; Kim CY; Kim M; Seong GJ
    Br J Ophthalmol; 2022 Aug; 106(8):1150-1156. PubMed ID: 33737305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
    Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
    Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.
    Rezkallah A; Mathis T; Abukhashabah A; Voirin N; Malclès A; Agard É; Lereuil T; Denis P; Dot C; Kodjikian L
    Retina; 2021 Jul; 41(7):1438-1445. PubMed ID: 33315814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
    Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
    Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure monitoring post intravitreal steroids: a systematic review.
    Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
    Surv Ophthalmol; 2013; 58(4):291-310. PubMed ID: 23768920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases.
    Rezkallah A; Mathis T; Denis P; Kodjikian L
    J Glaucoma; 2019 Jan; 28(1):e5-e9. PubMed ID: 30234749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axial Length as a Risk Factor for Steroid-Induced Ocular Hypertension.
    Choi W; Kim JD; Bae HW; Kim CY; Seong GJ; Kim M
    Yonsei Med J; 2022 Sep; 63(9):850-855. PubMed ID: 36031785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of selective laser trabeculoplasty as an alternative in patients who developed ocular hypertension after intravitreal dexamethasone implants: a series of 35 eyes.
    Billant J; Agard E; Douma I; Levron A; Brunet O; Remignon CH; Sejournet L; Dot C
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3665-3673. PubMed ID: 35665853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice.
    Hemarat K; Kemmer JD; Porco TC; Eaton AM; Khurana RN; Stewart JM
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):680-685. PubMed ID: 30222802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
    Chan LW; Hsu WC; Hsieh YT
    J Glaucoma; 2016 Mar; 25(3):e268-72. PubMed ID: 26950466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
    Polski A; Liu KC; Gupta D; Grewal DS; Horns J; Wirostko BM; Stagg BC
    BMJ Open Ophthalmol; 2023 Dec; 8(1):. PubMed ID: 38135349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.